A cura di Alessandra Russo. Specialista in Tossicologia Medica. Messina
|
Principio attivo |
Effetto |
|
Antiacidi (1) |
Possibile riduzione dell’efficacia del gabapentin |
|
Ginkgo (2-4) |
Possibile riduzione dell’efficacia del gabapentin |
|
Morfina (5,6) |
Possibile aumento delle concentrazioni plasmatiche di gabapentin |
|
Orlistat (7) |
Possibile riduzione dell’efficacia del gabapentin |
Bibliografia
- Product Information: Neurontin(R), gabapentin. Pfizer, Inc., New York, NY, 05/2002.
- Arenz A, et al. Occurrence of neurotoxic 4′-0-methylpyridoxine in Ginkgo biloba leaves, Ginkgo medications and Japanese Ginkgo food. Planta Medica 1996; 62: 548-551.
- Granger AS. Ginkgo biloba precipitating epileptic seizures. Age Ageing 2001; 30: 523-525.
- Yagi M, et al. Studies on the constituents of edible and medicinal plants. IV. Determination of 4′-O-methylpyridoxine in serum of the patient with Gin-nan food poisoning. Yakugaku Zasshi 1993; 113: 596-99.
- Product Information: GRALISE(R) oral tablets, gabapentin oral tablets. Abbott Laboratories, North Chicago, IL, Jan, 2011.
- Product Information: Neurontin(R) oral capsules, tablets, solution, gabapentin oral capsules, tablets, solution. Parke-Davis, New York, NY, Jul, 2010.
- Product Information: XENICAL(R) oral capsules, orlistat oral capsules. Genentech USA Inc. (per FDA), South San Francisco, CA, Oct, 2013.
Link
- Pregabalin
- Problemi respiratori associati a trattamento con gabapentin o pregabalin. FDA 19 dicembre 2019